Brokerage Firm Jefferies upgraded bluebird bio Inc. (NASDAQ:BLUE) shares from Hold to Buy rating while increasing their price target from $130 to $211.
bluebird bio, Inc. is a clinical-stage biotechnology company. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing.
Investment Analysts at Barclays upgraded Discover Financial Services (NYSE:DFS) shares from Equal Weight to Overweight rating while increasing their price target from $73 to $93.
Discover Financial Services is a direct banking and payment services company.
First Solar Inc. (NASDAQ:FSLR) shares were upgraded by analysts at Robert W. Baird from Neutral to Outperform rating while increasing their price target from $69 to $82.
First Solar, Inc. is a solar energy solutions company, which engages in the designing, manufacturing, marketing, and distribution of photovoltaic solar power systems and solar modules.
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/